FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:CDH11-KIFC3

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: CDH11-KIFC3
FusionPDB ID: 14978
FusionGDB2.0 ID: 14978
HgeneTgene
Gene symbol

CDH11

KIFC3

Gene ID

1009

3801

Gene namecadherin 11kinesin family member C3
SynonymsCAD11|CDHOB|ESWS|OB|OSF-4-
Cytomap

16q21

16q21

Type of geneprotein-codingprotein-coding
Descriptioncadherin-11cadherin 11, type 2, OB-cadherin (osteoblast)kinesin-like protein KIFC3
Modification date2020031320200327
UniProtAcc

P55287

Main function of 5'-partner protein: FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types.

Q9BVG8

Main function of 5'-partner protein: FUNCTION: Minus-end microtubule-dependent motor protein. Involved in apically targeted transport (By similarity). Required for zonula adherens maintenance. {ECO:0000250, ECO:0000269|PubMed:19041755}.
Ensembl transtripts involved in fusion geneENST idsENST00000394156, ENST00000268603, 
ENST00000566827, ENST00000569624, 
ENST00000566975, ENST00000379655, 
ENST00000421376, ENST00000445690, 
ENST00000465878, ENST00000539578, 
ENST00000540079, ENST00000541240, 
ENST00000543930, ENST00000562903, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score7 X 9 X 5=3156 X 6 X 3=108
# samples 135
** MAII scorelog2(13/315*10)=-1.27684020535882
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(5/108*10)=-1.11103131238874
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: CDH11 [Title/Abstract] AND KIFC3 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: CDH11 [Title/Abstract] AND KIFC3 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)CDH11(64982512)-KIFC3(57795448), # samples:2
Anticipated loss of major functional domain due to fusion event.CDH11-KIFC3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CDH11-KIFC3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
CDH11-KIFC3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
CDH11-KIFC3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:64982512/chr16:57795448)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across CDH11 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across KIFC3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000394156CDH11chr1664982512-ENST00000465878KIFC3chr1657795448-397725274542616720
ENST00000394156CDH11chr1664982512-ENST00000379655KIFC3chr1657795448-394825274542616720
ENST00000394156CDH11chr1664982512-ENST00000445690KIFC3chr1657795448-397525274542616720
ENST00000394156CDH11chr1664982512-ENST00000421376KIFC3chr1657795448-376625274542616720
ENST00000394156CDH11chr1664982512-ENST00000541240KIFC3chr1657795448-374925274542616720
ENST00000394156CDH11chr1664982512-ENST00000540079KIFC3chr1657795448-373525274542616720
ENST00000394156CDH11chr1664982512-ENST00000543930KIFC3chr1657795448-366225274542616720
ENST00000394156CDH11chr1664982512-ENST00000562903KIFC3chr1657795448-347425274542616720
ENST00000394156CDH11chr1664982512-ENST00000539578KIFC3chr1657795448-336925274542616720

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000394156ENST00000465878CDH11chr1664982512-KIFC3chr1657795448-0.0026794740.9973206
ENST00000394156ENST00000379655CDH11chr1664982512-KIFC3chr1657795448-0.0025824510.99741757
ENST00000394156ENST00000445690CDH11chr1664982512-KIFC3chr1657795448-0.002669990.99733007
ENST00000394156ENST00000421376CDH11chr1664982512-KIFC3chr1657795448-0.0030622080.99693775
ENST00000394156ENST00000541240CDH11chr1664982512-KIFC3chr1657795448-0.0031157820.99688417
ENST00000394156ENST00000540079CDH11chr1664982512-KIFC3chr1657795448-0.0030422780.9969578
ENST00000394156ENST00000543930CDH11chr1664982512-KIFC3chr1657795448-0.0030346080.99696535
ENST00000394156ENST00000562903CDH11chr1664982512-KIFC3chr1657795448-0.0028742310.9971258
ENST00000394156ENST00000539578CDH11chr1664982512-KIFC3chr1657795448-0.00290680.9970932

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for CDH11-KIFC3

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
CDH11chr1664982512KIFC3chr16577954482527689PFLYVVATESPTTLTGPARERASGKT

Top

Potential FusionNeoAntigen Information of CDH11-KIFC3 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CDH11-KIFC3_64982512_57795448.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CDH11-KIFC3chr1664982512chr16577954482527HLA-B35:03VATESPTTL0.92890.8844514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B15:37VATESPTTL0.92650.7773514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B15:10VATESPTTL0.92590.7391514
CDH11-KIFC3chr1664982512chr16577954482527HLA-A68:03TLTGPARER0.92090.69621221
CDH11-KIFC3chr1664982512chr16577954482527HLA-B51:02VATESPTTL0.90830.5883514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B15:16VATESPTTL0.90470.9112514
CDH11-KIFC3chr1664982512chr16577954482527HLA-A68:08TLTGPARER0.89830.7281221
CDH11-KIFC3chr1664982512chr16577954482527HLA-A68:05TLTGPARER0.88610.721221
CDH11-KIFC3chr1664982512chr16577954482527HLA-B52:01VATESPTTL0.84610.9903514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B46:01VATESPTTL0.84330.6402514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B14:01VATESPTTL0.8330.8983514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B14:02VATESPTTL0.8330.8983514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B45:01TESPTTLTG0.83090.891716
CDH11-KIFC3chr1664982512chr16577954482527HLA-B51:01VATESPTTL0.80110.6119514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B35:02VATESPTTL0.78790.9741514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B35:04VATESPTTL0.78790.9741514
CDH11-KIFC3chr1664982512chr16577954482527HLA-A34:02TLTGPARER0.78230.52651221
CDH11-KIFC3chr1664982512chr16577954482527HLA-A34:01TLTGPARER0.71830.58411221
CDH11-KIFC3chr1664982512chr16577954482527HLA-A34:05TLTGPARER0.71830.58411221
CDH11-KIFC3chr1664982512chr16577954482527HLA-A66:03TLTGPARER0.56930.71111221
CDH11-KIFC3chr1664982512chr16577954482527HLA-A68:24TTLTGPARER0.99320.71871121
CDH11-KIFC3chr1664982512chr16577954482527HLA-A68:03TTLTGPARER0.98940.68851121
CDH11-KIFC3chr1664982512chr16577954482527HLA-B45:01TESPTTLTGP0.97530.882717
CDH11-KIFC3chr1664982512chr16577954482527HLA-A68:08TTLTGPARER0.96320.73221121
CDH11-KIFC3chr1664982512chr16577954482527HLA-A68:05TTLTGPARER0.95540.70911121
CDH11-KIFC3chr1664982512chr16577954482527HLA-A68:06TTLTGPARER0.95530.61831121
CDH11-KIFC3chr1664982512chr16577954482527HLA-B50:02TESPTTLTGP0.9190.7222717
CDH11-KIFC3chr1664982512chr16577954482527HLA-A31:06TTLTGPARER0.9150.69841121
CDH11-KIFC3chr1664982512chr16577954482527HLA-B50:01TESPTTLTGP0.8580.7809717
CDH11-KIFC3chr1664982512chr16577954482527HLA-A66:03TTLTGPARER0.85480.73071121
CDH11-KIFC3chr1664982512chr16577954482527HLA-B41:01TESPTTLTGP0.74610.7999717
CDH11-KIFC3chr1664982512chr16577954482527HLA-B45:01TESPTTLTGPA0.99750.9051718
CDH11-KIFC3chr1664982512chr16577954482527HLA-B50:02TESPTTLTGPA0.99230.7312718
CDH11-KIFC3chr1664982512chr16577954482527HLA-B41:01TESPTTLTGPA0.9920.8429718
CDH11-KIFC3chr1664982512chr16577954482527HLA-B50:01TESPTTLTGPA0.9680.847718
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:15ATESPTTL10.9697614
CDH11-KIFC3chr1664982512chr16577954482527HLA-C05:09ATESPTTL10.9609614
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:13ATESPTTL0.98570.9868614
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:04ATESPTTL0.98570.9868614
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:19VATESPTTL0.99960.9929514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:08VATESPTTL0.99950.9376514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:07VATESPTTL0.99940.9884514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C15:04VATESPTTL0.9990.949514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C05:09VATESPTTL0.99890.9721514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C04:07VATESPTTL0.99860.8451514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C15:06VATESPTTL0.99860.9454514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C04:10VATESPTTL0.99860.8036514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:15VATESPTTL0.99760.9776514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C04:06VATESPTTL0.99650.9631514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C01:17VATESPTTL0.99540.9521514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:13VATESPTTL0.99390.9889514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:04VATESPTTL0.99390.9889514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B54:01SPTTLTGPA0.98730.6652918
CDH11-KIFC3chr1664982512chr16577954482527HLA-C06:03VATESPTTL0.98690.993514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C04:14VATESPTTL0.98640.8702514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C12:04VATESPTTL0.98450.9918514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C12:12VATESPTTL0.98260.9492514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C12:16VATESPTTL0.98060.9676514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C01:30VATESPTTL0.97850.9635514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B14:03VATESPTTL0.93280.8671514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:14VATESPTTL0.86510.9887514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:03VATESPTTL0.85930.988514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B51:07VATESPTTL0.81860.8887514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C07:13VATESPTTL0.79460.9516514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B35:12VATESPTTL0.78790.9741514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C02:06VATESPTTL0.74810.9549514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C07:29VATESPTTL0.69870.9509514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C07:27VATESPTTL0.68980.9704514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B39:09VATESPTTL0.61410.8356514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C07:19VATESPTTL0.58240.8719514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B39:10VATESPTTL0.53850.9268514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C07:95VATESPTTL0.52380.7584514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:07VVATESPTTL0.99890.9848414
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:08VVATESPTTL0.99850.9068414
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:19VVATESPTTL0.99840.991414
CDH11-KIFC3chr1664982512chr16577954482527HLA-A68:01TTLTGPARER0.99320.71871121
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:08YVVATESPTTL0.99960.8547314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:19YVVATESPTTL0.99960.9857314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:07YVVATESPTTL0.99920.9822314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:04YVVATESPTTL0.99780.98314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:13YVVATESPTTL0.99780.98314
CDH11-KIFC3chr1664982512chr16577954482527HLA-B40:06TESPTTLTGPA0.99590.8387718
CDH11-KIFC3chr1664982512chr16577954482527HLA-C02:06YVVATESPTTL0.99570.9533314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:03YVVATESPTTL0.98470.984314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C04:03ATESPTTL10.8762614
CDH11-KIFC3chr1664982512chr16577954482527HLA-C05:01ATESPTTL10.9609614
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:02ATESPTTL10.9697614
CDH11-KIFC3chr1664982512chr16577954482527HLA-B07:13ATESPTTL0.53940.8561614
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:03VATESPTTL0.99960.9913514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:04VATESPTTL0.99960.9913514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:67VATESPTTL0.99940.9869514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:17VATESPTTL0.99920.973514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:05VATESPTTL0.99920.9436514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C15:09VATESPTTL0.9990.949514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C04:03VATESPTTL0.99890.89514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C05:01VATESPTTL0.99890.9721514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:02VATESPTTL0.99870.9845514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C04:01VATESPTTL0.99860.8451514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C15:02VATESPTTL0.99840.922514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C15:05VATESPTTL0.99840.9394514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C18:01VATESPTTL0.9980.8426514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C06:06VATESPTTL0.99790.9918514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C01:03VATESPTTL0.99790.95514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:02VATESPTTL0.99760.9776514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C04:04VATESPTTL0.99670.9542514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C01:02VATESPTTL0.9960.9505514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C16:04VATESPTTL0.99210.9768514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:06VATESPTTL0.99020.9909514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C12:03VATESPTTL0.98960.9792514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C12:02VATESPTTL0.97820.9725514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C06:17VATESPTTL0.96330.9916514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C06:02VATESPTTL0.96330.9916514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C16:01VATESPTTL0.93720.9876514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B35:13VATESPTTL0.91280.8868514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C16:02VATESPTTL0.86240.9953514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:01VATESPTTL0.85930.988514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B51:06VATESPTTL0.84260.6182514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B35:22VATESPTTL0.84150.5497514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B78:02VATESPTTL0.8310.8781514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C07:04VATESPTTL0.79940.9235514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B35:09VATESPTTL0.78790.9741514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C02:02VATESPTTL0.77920.9796514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C02:10VATESPTTL0.77920.9796514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B51:14VATESPTTL0.77220.562514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C07:22VATESPTTL0.72740.6941514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C07:17VATESPTTL0.72080.982514
CDH11-KIFC3chr1664982512chr16577954482527HLA-A66:02TLTGPARER0.67870.71291221
CDH11-KIFC3chr1664982512chr16577954482527HLA-C06:08VATESPTTL0.6750.9933514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B15:30VATESPTTL0.64740.9473514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B15:73VATESPTTL0.63840.9723514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C17:01VATESPTTL0.62520.98514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B07:13VATESPTTL0.59790.8362514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C07:01VATESPTTL0.54890.7532514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B15:09VATESPTTL0.54740.9333514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B39:02VATESPTTL0.53890.9624514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B51:21VATESPTTL0.37770.5718514
CDH11-KIFC3chr1664982512chr16577954482527HLA-B40:21VATESPTTL0.08480.6265514
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:03VVATESPTTL0.99890.9892414
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:04VVATESPTTL0.99890.9892414
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:05VVATESPTTL0.99730.9414414
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:17VVATESPTTL0.99710.9758414
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:06VVATESPTTL0.96810.9901414
CDH11-KIFC3chr1664982512chr16577954482527HLA-B15:30VVATESPTTL0.95450.9297414
CDH11-KIFC3chr1664982512chr16577954482527HLA-B15:73VVATESPTTL0.94930.9702414
CDH11-KIFC3chr1664982512chr16577954482527HLA-B07:13VVATESPTTL0.94530.8131414
CDH11-KIFC3chr1664982512chr16577954482527HLA-C17:01VVATESPTTL0.91390.9744414
CDH11-KIFC3chr1664982512chr16577954482527HLA-B50:05TESPTTLTGP0.8580.7809717
CDH11-KIFC3chr1664982512chr16577954482527HLA-B50:04TESPTTLTGP0.8580.7809717
CDH11-KIFC3chr1664982512chr16577954482527HLA-A66:02TTLTGPARER0.85740.73021121
CDH11-KIFC3chr1664982512chr16577954482527HLA-B35:13VVATESPTTL0.82150.8515414
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:05YVVATESPTTL0.99960.9123314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:04YVVATESPTTL0.99960.9808314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:03YVVATESPTTL0.99960.9808314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:17YVVATESPTTL0.99920.9673314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C03:06YVVATESPTTL0.99670.9824314
CDH11-KIFC3chr1664982512chr16577954482527HLA-B07:13YVVATESPTTL0.98950.7994314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C08:01YVVATESPTTL0.98470.984314
CDH11-KIFC3chr1664982512chr16577954482527HLA-C17:01YVVATESPTTL0.98010.9625314
CDH11-KIFC3chr1664982512chr16577954482527HLA-B35:13YVVATESPTTL0.9770.8484314
CDH11-KIFC3chr1664982512chr16577954482527HLA-B50:05TESPTTLTGPA0.9680.847718
CDH11-KIFC3chr1664982512chr16577954482527HLA-B50:04TESPTTLTGPA0.9680.847718

Top

Potential FusionNeoAntigen Information of CDH11-KIFC3 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
CDH11-KIFC3_64982512_57795448.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
CDH11-KIFC3chr1664982512chr16577954482527DRB1-0902PFLYVVATESPTTLT015

Top

Fusion breakpoint peptide structures of CDH11-KIFC3

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
648ATESPTTLTGPARECDH11KIFC3chr1664982512chr16577954482527

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of CDH11-KIFC3

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN648ATESPTTLTGPARE-7.9962-8.1096
HLA-B14:023BVN648ATESPTTLTGPARE-5.70842-6.74372
HLA-B52:013W39648ATESPTTLTGPARE-6.83737-6.95077
HLA-B52:013W39648ATESPTTLTGPARE-4.4836-5.5189
HLA-A11:014UQ2648ATESPTTLTGPARE-10.0067-10.1201
HLA-A11:014UQ2648ATESPTTLTGPARE-9.03915-10.0745
HLA-A24:025HGA648ATESPTTLTGPARE-6.56204-6.67544
HLA-A24:025HGA648ATESPTTLTGPARE-5.42271-6.45801
HLA-B44:053DX8648ATESPTTLTGPARE-7.85648-8.89178
HLA-B44:053DX8648ATESPTTLTGPARE-5.3978-5.5112
HLA-A02:016TDR648ATESPTTLTGPARE-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of CDH11-KIFC3

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
CDH11-KIFC3chr1664982512chr16577954481121TTLTGPARERCTTACGGGACCTGCTAGGGAAAGAGCCTCA
CDH11-KIFC3chr1664982512chr16577954481221TLTGPARERACGGGACCTGCTAGGGAAAGAGCCTCA
CDH11-KIFC3chr1664982512chr1657795448314YVVATESPTTLGTGGCTACAGAGAGTCCAACCACACTTACGGGA
CDH11-KIFC3chr1664982512chr1657795448414VVATESPTTLGCTACAGAGAGTCCAACCACACTTACGGGA
CDH11-KIFC3chr1664982512chr1657795448514VATESPTTLACAGAGAGTCCAACCACACTTACGGGA
CDH11-KIFC3chr1664982512chr1657795448614ATESPTTLGAGAGTCCAACCACACTTACGGGA
CDH11-KIFC3chr1664982512chr1657795448716TESPTTLTGAGTCCAACCACACTTACGGGACCTGCT
CDH11-KIFC3chr1664982512chr1657795448717TESPTTLTGPAGTCCAACCACACTTACGGGACCTGCTAGG
CDH11-KIFC3chr1664982512chr1657795448718TESPTTLTGPAAGTCCAACCACACTTACGGGACCTGCTAGGGAA
CDH11-KIFC3chr1664982512chr1657795448918SPTTLTGPAACCACACTTACGGGACCTGCTAGGGAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
CDH11-KIFC3chr1664982512chr1657795448015PFLYVVATESPTTLTCTCTATGTGGTGGCTACAGAGAGTCCAACCACACTTACGGGACCT

Top

Information of the samples that have these potential fusion neoantigens of CDH11-KIFC3

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SKCMCDH11-KIFC3chr1664982512ENST00000394156chr1657795448ENST00000379655TCGA-EE-A2MN-06A

Top

Potential target of CAR-T therapy development for CDH11-KIFC3

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneCDH11chr16:64982512chr16:57795448ENST00000394156-1314618_640691694.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to CDH11-KIFC3

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to CDH11-KIFC3

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource